Table 3 Breast cancer characteristics of (a) estrogen receptor (ER), (b) progesterone (PR), (c) human epidermal growth factor receptor II (HER2), (d) grade, and (e) pathological stage distributions between women with initial screening/diagnostic mammography
(a) | ||||||
The first mammography | ER (%) | |||||
Negative | Positive | Total | ||||
Diagnostic | 11 (18.6) | 516 (81.4) | 634 | |||
Screening | 45 (15.5) | 245 (84.5) | 290 | |||
Total | 163 | 761 | 924 | |||
(b) | ||||||
The first mammography | PR (%) | |||||
Negative | Positive | Total | ||||
Diagnostic | 175 (27.7) | 456 (72.3) | 631 | |||
Screening | 65 (22.3) | 226 (77.7) | 291 | |||
Total | 240 | 682 | 922 | |||
(c) | ||||||
The first mammography | HER2 (%) | |||||
Negative | Equivocal | Positive | Total | |||
Diagnostic | 470 (74.8) | 5 (0.8) | 153 (24.4) | 628 | ||
Screening | 213 (74.2) | 13 (4.5) | 61 (21.3) | 287 | ||
Total | 683 | 18 | 214 | 915 | ||
(d) | ||||||
The first mammography | Grade (%) | |||||
I | II | III | Total | |||
Diagnostic | 47 (7.6) | 413 (66.7) | 159 (25.7) | 619 | ||
Screening | 33 (11.5) | 204 (71.1) | 50 (17.4) | 287 | ||
Total | 80 | 617 | 209 | 906 | ||
(e) | ||||||
Pathological stage | The first mammography | |||||
Diagnostic | Screening | Total | ||||
0 | 84 (14.26) | 73 (25.7) | 157 | |||
I | 195 (33.1) | 117 (41.19) | 312 | |||
II | 196 (33.2) | 71 (25) | 267 | |||
III | 78 (13.2) | 19 (6.69) | 97 | |||
IV | 36 (6.11) | 4 (0.14) | 40 | |||
Total | 589 | 284 | 873 | |||